retatrutide phase 2 results 2024 2025 type diabetes trial Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just Lilly's triple agonist achieves 16.8%
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14



























